A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 8 of the 12 sources its claims cite were checked for support.
Abstract
The excess LYLs in four types of SMIs were as follows: for schizophrenia, 12.87 years in males and 11.92 years in females; for bipolar disorder, 8.43 years in males and 5.54 years in females; for paranoid disorder, 13.90 years in males and 14.03 years in females; and for schizoaffective disorder, 16.69 years in males and 15.82 years in females, when compared to the general population. Individuals with SMI had nearly twice the all-cause mortality of the general population (adjusted SMR 1.96, 95% CI 1.94-1.98). Elevated mortality rates were observed across all types of SMIs, with SMRs varying from 1.23 to 2.96.
Overview
CoChat Summary
## TL;DR
This retrospective population-based study of 321,436 people with severe mental illness (SMI) in Jiangsu, China found substantial premature mortality, with excess life-years lost ranging from 5.54 to 16.69 years depending on diagnosis and sex. Overall all-cause mortality was nearly doubled versus the general population (adjusted SMR 1.96), with cause-specific patterns showing especially high risks for suicide, accidents, and several physical diseases.
## Key findings
- Among 321,436 individuals with SMI, 33,947 died during follow-up from January 2014 to December 2022.
- Excess life-years lost varied by diagnosis and sex: schizophrenia 12.87 years in males and 11.92 in females; bipolar disorder 8.43 and 5.54; paranoid disorder 13.90 and 14.03; schizoaffective disorder 16.69 and 15.82.
- All-cause mortality was nearly doubled relative to the general population overall (adjusted SMR 1.96, 95% CI 1.94–1.98), with diagnosis-specific all-cause SMRs of 2.19 for schizophrenia, 1.23 for bipolar disorder, 1.94 for paranoid psychosis, and 2.15 for schizoaffective disorder.
- The leading causes of death across SMI groups were cerebrovascular disease (22.04%–25.06%), neoplasms (13.27%–17.94%), cardiovascular disease (12.80%–15.23%), and accidents (12.06%–13.13%); suicide SMRs were especially high, ranging from 6.16 to 14.81.
## Methods
- Retrospective, population-based study using the Jiangsu Province Management Information System for Patients with SMI, with data from January 2014 to December 2022; diagnoses required concordance by at least two specialist psychiatrists.
- Included 321,436 people with one of four SMI diagnoses: schizophrenia, bipolar disorder, schizoaffective disorder, or paranoid disorder; extracted sex, birth date, diagnosis date, death date, and primary cause of death.
- Calculated excess life-years lost separately by sex and diagnosis, and estimated standardized mortality ratios (SMRs) for all-cause and cause-specific mortality using age-, sex-, and calendar-time-standardized comparisons with the general population; 95% CIs used bootstrap for LYLs and Poisson regression for SMRs.
## Limitations
- The paper states that a very small percentage of SMI cases may not have been identified or diagnosed and thus not included.
- The study did not include major depressive disorder because it is not classified as SMI in China; this limits scope, as stated in the paper.
- The authors note that expanding from Jiangsu to the whole country would improve generalizability.
- The paper states that unmeasured confounding such as economic status could affect results.
- The text also makes evident a limitation: only the earliest recorded diagnosis was used, so diagnostic changes over time were not captured (stated in the paper).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
7 Valid · 1 Not valid · 0 Not checked · 57 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The excess mortality observed in SMI is driven predominantly by natural rather than unnatural causes [14, 15].”
§ A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China > Background Mental health issues have emerged as significant public health and societal challenges, impacting economic and social progress. As per statistics from the Chinese Center for Disease Control and Prevention (CDC), mental disorders account for 20% of the total disease burden in China [1]. Among these, severe mental illnesses (SMI) drastically affect patients’ quality of life and create substantial disease burdens. Currently, there is inconsistency in the practical definition of SMI, with narrower definitions focusing on psychotic disorders like schizophrenia and bipolar disorder, while broader definitions encompass a wider array of conditions [2]. In China, the government focuses on addressing priority mental health conditions that pose a heightened risk of violent or socially disruptive behaviors, driven by resource limitations and a primary concern for social stability [3]. Thus, six mental disorders: schizophrenia, bipolar disorder, schizoaffective disorder, paranoid disorder, mental disorder caused by epilepsy, and intellectual disability, are classified as priority mental health conditions in China [4, 5]. It is estimated that there were over six million patients registered with those priority mental health conditions in China, with a reported prevalence rate of 0.43% [6]. Since the strengthening of the government’s supervision of these individuals, the proportion of aggressive behavior decreased markedly [7]. The persistent issue of excessive and premature mortality rates among individuals with SMI remains a grave concern, warranting further investigations to understand and address this public health challenge effectively. To date, numerous studies have explored premature mortality in individuals with SMI, revealing a stark reality where individuals with SMI experience significantly shorter life expectancies compared to the general population. Reports indicate that individuals with SMI may face death 10 to 20 years earlier than the general population, particularly impacting male patients [8]. Furthermore, the mortality rate among individuals with SMI is estimated to be 2 to 3 times higher than that of the general population [9, 10]. Evidence also suggests that the gap of life expectancy between SMI and the general population may be increasing over time [11]. Additionally, due to the differences in diet structure, lifestyle, and even genetic background, the life expectancy of patients with SMI is also different across countries and regions [8, 12]. For instance, a study in Ethiopia revealed a 30-year lower life expectancy for individuals with SMI compared to the general population [10], while a systematic review highlighted an average of 14.5 years of potential life lost in schizophrenia patients compared to the general population [13]. A recent study in China reported a premature mortality of 15.82 years in schizophrenia patients, with male and female patients experiencing 15.82 and 14.59 years of premature mortality, respectively [14]. Most studies have focused on specific types of SMIs and have primarily been conducted in Western countries, leaving limited evidence on the lifespan of individuals with SMI in China, particularly concerning premature mortality across the spectrum of these disorders within the same timeframe. The excess mortality observed in SMI is driven predominantly by natural rather than unnatural causes [14, 15]. It is widely acknowledged that individuals with SMI face an elevated risk of developing physical comorbidities due to poor dietary habits, higher rates of substance use, limited physical activity, social engagement, and the adverse effects of antipsychotic and other medications [12, 16]. Population-based studies indicate that approximately 79% of the disparity in life expectancy between individuals with SMI and the general population can be linked to cardiovascular, respiratory, cancer, metabolic, and infectious diseases [17]. A comprehensive meta-analysis revealed that 67.3% of deaths in individuals with mental disorders result from physical illnesses, while 17.5% are due to unnatural causes[18]. Among physical illnesses, cardiovascular disease emerges as the leading cause of premature mortality in individuals with SMI, as supported by substantial evidence [19–22]. However, a cohort study conducted in London during 2013–2017 suggested that deaths from cancer may surpass those from cardiovascular disease in patients with SMI [23]. While a limited number of domestic studies have explored the causes of death in individuals with SMI, they either lack specific descriptions of physical disease causes [24, 25]or focus on a singular type of SMI [14, 26]. Although the decreased life expectancy in individuals with SMI is driven chiefly by natural causes, the toll of unnatural deaths, such as suicide and accidents (including road accidents, drownings, accidental falls, and others), remains alarmingly high among those individuals. A prospective cohort study conducted in the USA revealed that nearly half of individuals who died by suicide had a history of mental health diagnoses or had received related treatment [27]. In a recent study from Taiwan, it was found that 12% of schizophrenia patients died by suicide, representing the primary cause of unnatural death in this population [28]. However, past research has indicated that individuals with SMI are two to four times more likely to die from accidents compared to the general population, with accidents being a more prevalent unnatural cause of death than suicide in this patient group [29]. Hence, a comprehensive assessment of both natural and unnatural causes of death is essential to fully understand the life-expectancy gap in this vulnerable population. In the present study, we conducted a retrospective study to systematically collect mortality data for individuals with SMIs (including schizophrenia, bipolar disorder, schizoaffective disorder and paranoid disorder) in Jiangsu, China, alongside data for the general population in the same geographical area during the same timeframe. The objectives of this study were (1) to calculate the excess life-years lost (LYLs) from age at first diagnosis in individuals with each specific SMI, separately by sex, as an indicator of the differences in average life expectancy compared to the general population; and (2) to analyze the causes of death among individuals with different types of SMIs and estimate the all-cause and cause-specific relative risks in SMI patients compared to the general population.
What the sources say
- Partly supportedcites [14] Ren J, Duan Y, Wang J, Sun Y, Wang M, Geng Z, et al. Mortality and excess life-years lost in patients with schizophrenia under community care: A 5-year follow-up cohort study. Braz J Psychiatry. 2023;45(3):216–25. sourceExperimental — accuracy not yet measured
The Results (Cause-specific SMRs) attribute 65.78% of excess mortality to natural causes and 14.67% to external injuries and poisoning, classified as unnatural causes. That supports the comparison for patients with schizophrenia under community care, but the claim extends it to severe mental illness (SMI) generally, which this study did not examine. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [15] Berardi D, Stivanello E, Chierzi F, Musti MA, Perlangeli V, Pandolfi P, et al. Mortality in mental health patients of the Emilia-Romagna region of Italy: a registry-based study. Psychiatry Res. 2021;296:113702. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Schizophrenia patients exhibited the highest SMR for suicide (SMR 10.89, 95% CI 10.25–11.56)”
§ A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the all-cause SMRs were 2.19 for schizophrenia (95% CI 2.17–2.22)”
§ A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“2.19 (95% CI 2.15–2.23) in males”
§ A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“specific SMRs of 3.87 for schizophrenia”
§ A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China > Discussion To date, only a scant few studies in China have examined the life expectancy and years of life lost in individuals with SMI, yet none have concurrently addressed schizophrenia, bipolar disorder, paranoid psychosis, and schizoaffective disorder in a single investigation. In a study by Liu et al., which involved 7907 deceased individuals with schizophrenia in western China in 2017, it was reported that the overall life expectancy of schizophrenia patients was 55.7 years, resulting in approximately 18.4 years of life lost compared to the general population [32]. An early longitudinal study in rural China, dating back to 1994, followed 510 patients with schizophrenia, finding that the life expectancy was 50.6 years for males and 58.5 years for females based on data from 139 deceased individuals by 2015, equating to a shortfall of 13.4 and 17.1 years compared to the general population during the same period [33]. Research from Taiwan revealed Life expectancies at birth for individuals with schizophrenia, with figures of 59.53 years for men and 65.65 years for women in cohort 2005, and 60.65 years for men and 67.18 years for women in cohort 2010. Meanwhile, life expectancies at birth were reported at 74.5 years for men and 80.8 years for women with bipolar disorder in Taiwan in 2005, and 76.15 years for men and 82.66 years for women in 2010, resulting in a loss of 12.69 to 15.53 years for patients with schizophrenia and bipolar disorder in Taiwan [34]. In the present study, we comprehensively analyzed mortality data for the entire province of Jiangsu from 2014 to 2022. Our findings revealed that individuals with SMIs had a shorter remaining life expectancy than the general population. The excess LYLs from age at diagnosis in the four types of SMIs were as follows: for schizophrenia, 12.87 years in males and 11.92 years in females; for bipolar disorder, 8.43 years in males and 5.54 years in females; for paranoid disorder, 13.90 years in males and 14.03 years in females; and for schizoaffective disorder, 16.69 years in males and 15.82 years in females, when compared to the general population. Together, our results highlight the profound mortality burden associated with SMIs in China. Studies conducted in South East London have reported similar alarming findings. In the 2008–2012 cohort, the life expectancy gap was 16.4 years for schizophrenia and 12.3 years for bipolar disorder. In the 2013–2017 cohort, the gap was 14.6 years for schizophrenia and 14.0 years for bipolar disorder [23]. Another study conducted in the UK with data from 2007 to 2014 demonstrated that the life expectancy gap was 15.0 for males and 13.3 for females in schizophrenia-spectrum disorder, and 12.6 for males and 13.1 for females in bipolar disorder [35]. A recent meta-analysis encompassing studies from 24 countries or regions calculated a pooled years of potential life lost of 14.66 years (male: 14.94, female: 13.14) in individuals with any mental disorders [36]. While direct comparisons among existing studies may be challenging due to varying observation periods, geographical regions, and definitions of severe mental disorders, the consensus remains that individuals with SMI have a diminished life expectancy compared to the general population. Thus, it is crucial to gain a deeper understanding of the phenomena and underlying causes of premature mortality in individuals with SMI. Furthermore, the significantly elevated mortality burden among individuals with SMI was also supported by the results of SMR calculation. Overall, the all-cause SMR for individuals with SMI was nearly double that of the general population, underscoring the profound impact of SMI on premature mortality. This elevated risk was consistent across all types of SMIs, with SMRs Ranging from 1.23 for bipolar disorder to 2.19 for schizophrenia. The sex- and diagnosis-specific differences in all-cause SMR may reflect variations in biological factors, healthcare access, or behavioral risks associated with different SMIs. These results align with earlier studies, such as the meta-analysis by Oakley et al. (2018), which reported SMRs fell to 2.8 for Males and 2.7 for females with schizophrenia in studies conducted after 2010, indicating a persistent but slightly declining mortality gap over time [37]. Similarly, our findings for schizophrenia and bipolar disorder are consistent with these trends, suggesting that while mortality risks remain high, they may have modestly decreased compared to earlier decades. However, Hayes et al. (2017) found that while overall mortality rates for schizophrenia and bipolar disorder decreased from 2000 to 2014, the relative mortality risks compared to the general population increased after adjusting for socio-demographic factors [38]. These findings, together with our results, underscore the persistent mortality risks for individuals with SMI, despite advances in mental and physical healthcare. Numerous studies have highlighted cardiovascular diseases as a predominant cause of death among individuals with SMI [20, 39, 40]. However, most of this evidence stems from research conducted in Western countries, and China’s domestic studies on the causes of death among SMI patients are scarce. Our systematic investigation aimed to address this gap and revealed that cerebrovascular diseases and cardiovascular diseases both rank as the primary causes of death in SMI patients, with the former accounting for a higher proportion. A recent 5-year follow-up cohort study in China also supported these findings, indicating that more individuals with schizophrenia succumbed to cerebrovascular diseases compared to cardiovascular events [14]. Additionally, the SMRs for cardiovascular diseases and cerebrovascular diseases among individuals with schizophrenia were approximately twice those of the general population [14]. In the present study, our findings also revealed that, while individuals with bipolar disorder had only slightly elevated risks of death from cardiovascular and cerebrovascular diseases compared to the general population, the SMRs for these causes of death in the other three types of SMI were nearly or more than double those of the general population. Therefore, there is a crucial need to monitor not only cardiovascular disease but also cerebrovascular disease in individuals with SMI. While several studies have suggested a lower incidence rate of neoplasms in individuals with, potentially attributed to protective biological and other mechanisms in these patients [41–43], there is growing evidence indicating a gradual increase in the incidence of neoplasms among individuals with SMI [44–46]. A national cohort study conducted in Denmark reported higher mortality rate ratios for neoplasm-related deaths among individuals with schizophrenia (1.38) and bipolar disorder (1.25) [31]. In our current study, we found that neoplasm accounted for a high proportion of deaths among individuals with all types of SMIs. Interestingly, the risk of death from neoplasm was lower in patients with bipolar disorder and paranoid psychosis compared to the general population, while for schizophrenia and schizoaffective disorders, the risk of death from neoplasm did not exceed 1.15 times that of the general population. Thus, it is essential for future research to delve deeper into the comorbidity of neoplasms and the associated burden of premature mortality in individuals with SMI. There is substantial evidence indicating that individuals with SMI are at a significantly higher risk of developing diabetes-related metabolic diseases, which is associated with the use of antipsychotic medications [47] and genetic comorbidities [48]. In this study, we found that the SMRs for diabetes-related deaths among individuals with all four types of SMIs were at least 1.86, with specific SMRs of 3.87 for schizophrenia, 1.82 for bipolar disorder, 3.13 for paranoid disorder, and 3.89 for schizoaffective disorder. These findings are largely consistent with previously reported international data, which documented diabetes-specific mortality rate ratios of 3.11 for schizophrenia and 2.09 for mood disorder [31]. Together, these results highlight the critical need for integrated care approaches that address mental and physical health challenges faced by individuals with SMI, to reduce premature mortality and improve long-term outcomes. It is well-established that patients with SMI are at a significantly higher risk of suicide and accidents compared to the general population [10, 49]. In the present study, we found elevated mortality risks for suicide and accidents across all types of SMIs, with SMRs ranging from 6.16 to 14.81 for suicide and from 2.15 to 4.01 for accidents. These findings are consistent with recent domestic studies, which reported prominent premature deaths due to suicide and accidents in patients with schizophrenia, with SMRs of 18.70 and 6.22, respectively [32]. Another contemporaneous study also demonstrated high SMRs for suicide (3.87) and accidents (4.13) in schizophrenia patients [25]. Similarly, data from Denmark revealed a mortality rate of 10.76 for suicide and 5.39 for accidents in schizophrenia [31], which closely align with our findings. These consistent findings highlight the urgent need for targeted interventions to reduce the risk of suicide and accidents, which could significantly mitigate years of potential life lost in individuals with SMI. Alcohol misuse is also a significant issue among individuals with SMI, contributing not only to increased rates of suicide attempts but also to mortality[50]. In this study, we found that individuals with schizophrenia had significantly elevated SMR for deaths related to alcohol misuse. The findings align with previous research from Denmark, highlighting the severe impact of alcohol misuse on mortality in these populations [31]. However, since the event of alcohol misuse death is less than ten among bipolar disorder, paranoid disorder, and schizoaffective disorder, precise SMR estimates could not be obtained. Hence, future studies with larger samples are warranted. The high mortality rate due to alcohol misuse in individuals with schizophrenia underscores the need for tailored interventions addressing alcohol misuse in these populations.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
38 more claims
Create a free account to see all 65 claims and every source verdict.
- Probably not a substantial claim. 13
- It may state two separate claims as one. 10
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Li Y, Yan LL, Ronsmans C, Wen H, Xu J, Wang D, et al. Excess mortality among patients with severe mental disorders and effects of community-based mental healthcare: A community-based prospective study in sichuan, china. BJPsych Open. 2021;7(3):e84.”
Cited work 10.1192/bjo.2021.46 · retracted 2021-04-22 · notice 10.1192/bjo.2024.38 · this paper published 2025-10-21
Citations
Cites
1 retracted
Li, Y., Yan, L. L., Ronsmans, C., Wen, H., Xu, J., Wang, D., & Yang, M. (2021) · BJPsych Open · doi:10.1192/bjo.2021.46 · Cited by 11
RetractedWalker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304 · cited 1×
“For instance, a study in Ethiopia revealed a 30-year lower life expectancy for individuals with SMI compared to the general population [10], while a systematic review highlighted an average of 14.5 years of potential life lost in schizophrenia patients compared to the general population [13].”
InfluentialLiu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., Druss, B., Dudek, K., Freeman, M., Fujii, C., et al. (2017) · World Psychiatry · doi:10.1002/wps.20384 · Cited by 865 · cited 1×
“Evidence also suggests that the gap of life expectancy between SMI and the general population may be increasing over time [11].”
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · cited 2×
“Additionally, due to the differences in diet structure, lifestyle, and even genetic background, the life expectancy of patients with SMI is also different across countries and regions [8, 12].”
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study
Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050599 · Cited by 619
Plana-Ripoll, O., Pedersen, C. B., Agerbo, E., Holtz, Y., Erlangsen, A., Canudas-Romo, V., Andersen, P. K., Charlson, F. J., Christensen, M. K., Erskine, H. E., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32316-5 · Cited by 595 · cited 7×
“The 95% CI of SMRs was estimated for each specific cause of death and for all causes combined in SMI using Poisson regression models, adjusting for sex, age, and calendar time[31].”
InfluentialDefinition and prevalence of severe and persistent mental illness
Ruggeri, M., Leese, M., Thornicroft, G., Bisoffi, G., & Tansella, M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.2.149 · Cited by 552 · cited 1×
“Currently, there is inconsistency in the practical definition of SMI, with narrower definitions focusing on psychotic disorders like schizophrenia and bipolar disorder, while broader definitions encompass a wider array of conditions [2].”
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014
Hayes, J. F., Marston, L., Walters, K., King, M. B., & Osborn, D. P. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.202606 · Cited by 451 · cited 1×
“However, Hayes et al. (2017) found that while overall mortality rates for schizophrenia and bipolar disorder decreased from 2000 to 2014, the relative mortality risks compared to the general population increased after adjusting for socio-demographic factors [38].”
Research works printed but not linked: 4
- Zhong Y. The realization framework and path of the collaborative supply of community mental health services under the “healthy china strategy.” Chinese journal of health policy. 2020;13(8):8–14.
- Wang X, Ma N, Wu X, Zhang W, Guan L, Ma H, et al. Analysis of the current status of management and treatment of patients with severe mental disorders nationwide in 2018. Chinese journal of psychiatry. 2020;53(5):438–45.
- Ma H, Liu J, He Y, Xie B, Xu Y, Hao W, et al. An important pathway of mental health service reform in china: Introduction of 686 program. J chinese mental health journal. 2011;25(10):725–8.
- Chan JKN, Correll CU, Wong CSM, Chu RST, Fung VSC, Wong GHS, et al. Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. EClin Med. 2023;65:102294.
Cited by
Cross-population validation of European GWAS loci for metabolic syndrome in Chinese schizophrenia
You, Y., Qiao, N., Chen, Y., Wang, Z., Zhuang, L., Fang, X., Tang, X., & Zhang, X.-B. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08144-4
“Glucose and lipid metabolic abnormalities substantially elevate mortality in SCZ; our group recently reported in MBC Medicine that SCZ patients have a 3.87-fold higher risk of death from diabetes than the general population [5].”
InfluentialSelf-citationGe, X., Jiang, C., Wu, C., Fang, X., & Zhang, X. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02325-8 · Cited by 1
Self-citationJiang, C., Wang, L., Zhang, S., Ge, X., Li, Y., Wu, C., Zhou, C., Tan, J., Sun, F., Qian, N., et al. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.07.018
Self-citationMahdavinoor, S. M. M., Mollaei, A., Golzar, M. H., Kargar-Soleimanabad, S., Bordbari, A., Amiri, M., Rafiee, M. H., & Seddigh, L. (2026) · BJPsych Open · doi:10.1192/bjo.2026.12068
“Finally, 24 articles 22,23, 31 – 52 were included in the study.”
Metadata
- Authors
- Fang, X., Yu, H., Wu, C., Tan, J., Sun, F., Qian, N., Zhou, H., Zhou, J., & Zhang, X.
- Affiliations
- Nanjing Brain Hospital (CN)
- Jiangsu Provincial Center for Disease Control and Prevention (CN)
- Corresponding author
- Zhou, Jinyi
- Zhang, Xiangrong
- Venue
- BMC Medicine
- Published
- 2025-10-21
- Volume
- 23
- Issue
- 1
- Pages
- 571-571
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC12538965
- OpenAlex
- W4415376592
- Cited by
- 5
- References
- 46
- Citations by year
- 2026: 5
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (YKK20090)
- the Science and Technology Development Program of Nanjing Medical University (NMUB2019107)
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (82371510, 82401761, 81971255 and 81571314)
- National Key Research and Development Program of China (2018YFC1314300 and 2016YFC1307002)
- Social Development Foundation of Jiangsu Province, China (BE2023668 and BE2019610)
- Jiangsu Provincial Medical Talent project (ZDRCA2016075)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- severe mental illness, mortality risk, causes of death, schizophrenia, bipolar disorder, delusional disorder, schizoaffective disorder, suicide, cardiovascular disease, infectious diseases, diabetes mellitus, sex differences, Jiangsu Province, China, standardized mortality ratio, population-based cohort, mental health service utilization, health equity, mental health professionals
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Cause of Death, Child, China, Female, Humans, Life Expectancy, Male, Middle Aged, Retrospective Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China. https://app.cochat.ai/papers/10.1186/s12916-025-04380-9
- The paper
- Fang, X., Yu, H., Wu, C., Tan, J., Sun, F., Qian, N., Zhou, H., Zhou, J., & Zhang, X. (2025). A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China. BMC Medicine. https://doi.org/10.1186/s12916-025-04380-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.